To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC2269 | Gls1 Inhibitor Ll202 |
Novel inhibitor of glutaminase 1 (GLS1) with high binding affinity (SPR, Kd = 24 nM; ITC, Kd = 37 nM), exhibiting a similar in vivo antitumor activity as CB839
More description
|
|
| DCC2268 | Glpg0259 |
The first-in-class, ATP-competitive inhibitor of MAPKAPK5
More description
|
|
| DCC2267 | Glp-2r Modulator I |
Ago-allosteric modulator of human GLP-2R
More description
|
|
| DCC2266 | Glp-2 (1-33) Acetate |
Enteroendocrine hormone, stimulating the growth of intestinal epithelium
More description
|
|
| DCC2265 | Glo1-in-9 |
Novel inhibitor of glyoxalase 1 (Glo1), increasing the cellular methylglyoxal levels in human cells and suppressing the osteoclast formation of mouse bone marrow-derived macrophages
More description
|
|
| DCC2264 | Glo1-in-60 |
Novel potent Glyoxalase 1 (GLO1) inhibitor, demonstrating to penetrate the blood-brain barrier, elevating levels of methylglyoxal in the brain, and reducing depression-like behavior in mice
More description
|
|
| DCC2263 | Glmu-in-5175178 |
Novel inhibitor of the acetyltransferase activity of Escherichia coli N-acetylglucosamine-1-phosphate-uridyltransferase/glucosamine-1-phosphate-acetyltransferase (GlmU).
More description
|
|
| DCC2262 | Glipentide |
Second-generation sulfonylurea, promoting the accumulation of fructose 2,6-bisphosphate in hepatocytes
More description
|
|
| DCC2261 | Glft2-in-31 |
Novel Galactofuranosyltransferase 2 (GlfT2) inhibitor
More description
|
|
| DCC2260 | Glenvastatin |
Novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor
More description
|
|
| DCC2259 | glaziovianin A |
Novel inhibitor of the cell cycle progression in M-phase; Inhibotor of endosome maturation
More description
|
|
| DCC2258 | Gkm001 |
First-in-class liver-selective glucokinase activator for the treatment of type 2 diabetes
More description
|
|
| DCC2257 | Gka-71 |
Novel and potent glucokinase activator (GKA)
More description
|
|
| DCC2256 | Gka-22 |
Novel Allosteric Activator of Human Glucokinase in the Absence of Glucose
More description
|
|
| DCC2255 | Gk-667 |
Novel water solubile prodrug of ICRF-193, penetrating into NVCMs, reaching intracellular concentrations sufficient to induce cytoprotective effects against ANT toxicity
More description
|
|
| DCC2254 | Gk-136901 |
First-in-Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitor
More description
|
|
| DCC2253 | Ginnalin A |
Natural Activator of the Nrf2-Regulated Antioxidant Defense System in SH-SY5Y Cells, Binding to the Subpockets of Keap1 Kelch Domain
More description
|
|
| DCC2252 | Ginkgonitroside |
Natural suppressor of mesenchymal stem cell (MSC) differentiation
More description
|
|
| DCC2250 | Gif-0856-r |
Novel suppressor of endoplasmic reticulum (ER) stress and oxidative stress, preventing protein aggregate accumulation in vitro and in cultured hippocampal HT22 neuronal cells, as well as glutamate-induced oxytosis and erastin-induced ferroptosis
More description
|
|
| DCC2249 | Gif-0854-r |
Novel suppressor of endoplasmic reticulum (ER) stress and oxidative stress, preventing protein aggregate accumulation in vitro and in cultured hippocampal HT22 neuronal cells, as well as glutamate-induced oxytosis and erastin-induced ferroptosis
More description
|
|
| DCC2248 | Gidazepam |
Potent mitochondrial benzodiazepine receptors (MBRs) ligand; Prodrug for its active metabolite bromo-nordazepam
More description
|
|
| DCC2247 | Gic-1001 |
Novel oral anti-nociceptive agent, showing peripheral opioid agonistic activity and hydrogen sulphide-releasing capacity
More description
|
|
| DCC2246 | Gi261520a |
Potent EGFR/erbB2 dual inhibitor
More description
|
|
| DCC2245 | Gi-129471 |
Metalloproteinase inhibitor, specifically blocking TNF-alpha secretion both in vitro and in vivo
More description
|
|
| DCC2244 | Ghsr Inverse Agonist 29 |
Novel nonpeptidic inverse agonist of the Ghrelin Receptor (GHSR)
More description
|
|
| DCC2243 | G-glu-glu |
Endogenous dipeptide, activating N-methyl-D-aspartate receptors
More description
|
|
| DCC2241 | Geopyxin F |
Natural non-covalent NRF2 activator, activating NRF2 in A KEAP1-dependent but Cys151-independent manner, conferring greater protection than a Cys151-dependent analog, geopyxin C
More description
|
|
| DCC2240 | Geopyxin C |
Natural covalent Cys151-dependent NRF2 activator
More description
|
|
| DCC2239 | Geneseroline |
Metabolite of ganstigmine, a novel acetylcholinesterase inhibitor
More description
|
|
| DCC2238 | Genaconazole |
Novel antifungal agent
More description
|
|